ABAkhil C. Banerjea

Akhil C. Banerjea

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Akhil C. Banerjea has a total of 88 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Dengue virus non-structural protein 1 disrupts the TGF-β/Smad signaling 

    by Anismrita Lahon, Ravi Arya, Vivek Kumar, Ritu Mishra, Akhil Banerjea

    TGF-β signaling is tightly regulated to ensure cellular functions. Role of DENV on the TGF-β/Smad signaling has not been well established. Therefore, we aimed to study the association between DENV infection and TGF-β/Smad signaling. We observed significant impairment in the expression of Smad2, Smad3, Smad4, Smad6 and Smad7 during DENV replication, which are the key players in TGF-β signaling. Significant reduction in the expression of phosphorylated Smad3 was also documented. Overexpression of Smad2/3/4/6 provided the evidence of slight inhibition on DENV replication indicating these Smads may work against the establishment of DENV replication. DENV non-structural protein 1 (NS1) was noted as crucial viral factor that impaired the expression of Smad2, Smad3 and Smad4 and also physically interacts with these proteins as confirmed by co-immunoprecipitation assay. Additionally, we observed NS1 is also capable of blocking the nuclear translocation of Smad3 and thus further ensuring inhibition of Smad signaling. To figure out degradation mechanisms, we studied the role of two distinct E3 ligases, CHIP and Smurf2, which are essential for the degradation of Smad proteins. Co-expression of Smad2/3/4 and NS1 with Smurf2, Smurf2mut, CHIP or use of CHIP-/- cells suggests that only Smurf2 has significant role in the degradation of Smad proteins during DENV infection. NS1 may acts as a co-factor with Smurf2 to escalate the proteasome and lysosome mediated degradation of Smad3 and Smad4 proteins respectively. Therefore, our results confirm that NS1 interacts with Smad proteins and reduces their expression by utilizing E3 ligase and disrupt the TGF-β/Smad signaling.

  • HIV-1 Nef promotes ubiquitination and proteasomal degradation of p53 tumor suppressor protein by using E6AP

    by Amjad Ali, Sabihur Rahman Farooqui, Jagdish Rai, Jyotsna Singh, Vivek Kumar, Ritu Mishra, Akhil C. Banerjea


  • Open Access

    Genetic Polymorphisms in the Open Reading Frame of the CCR5 gene From HIV-1 Seronegative and Seropositive Individuals From National Capital Regions of India

    by Larance Ronsard, Vikas Sood, Ashraf S. Yousif, Janani Ramesh, Vijay Shankar, Jishnu Das, N. Sumi, Tripti Rai, Kumaravel Mohankumar, Subhashree Sridharan, et al.

    C-C chemokine receptor type 5 (CCR5) serves as a co-receptor for Human immunodeficiency virus (HIV), enabling the virus to enter human CD4 T cells and macrophages. In the absence of CCR5, HIV strains that require CCR5 (R5 or M-tropic HIV) fail to successfully initiate infection. Various natural mutations of the CCR5 gene have been reported to interfere with the HIV-CCR5 interaction, which influences the rate of AIDS progression. Genetic characterization of the CCR5 gene in individuals from the National Capital Regions (NCRs) of India revealed several natural point mutations in HIV seropositive/negative individuals. Furthermore, we identified novel frame-shifts mutations in the CCR5 gene in HIV seronegative individuals, as well as the well reported CCR5Δ32 mutation. Additionally, we observed a number of mutations present only in HIV seropositive individuals. This is the first report to describe the genetic variations of CCR5 in individuals from the NCRs of India and demonstrates the utility of investigating understudied populations to identify novel CCR5 polymorphisms.


  • Open Access

    The host cell ubiquitin ligase protein CHIP is a potent suppressor of HIV-1 replication

    by Amjad Ali, Sabihur Rahman Farooqui, Akhil C. Banerjea


  • Open Access

    Suppressor of Cytokine Signaling 3 (SOCS3) Degrades p65 and Regulate HIV-1 Replication

    by Vikas Sood, Sneh Lata, Vishnampettai G. Ramachandran, Akhil C. Banerjea

    Human Immunodeficiency Virus-1 (HIV-1) is known to induce the expression of SOCS3 which is a negative feed-back regulator of inflammatory responses. Here, we demonstrate that reactivation of latent HIV-1 leads to degradation of SOCS3 at early time points. Interestingly, SOCS3 degradation following transfection of HIV-1 RNA as well as polyIC in THP-1 cells further confirmed the role of viral RNA signaling in SOCS3 biology. Degradation of SOCS3 contributes toward viral RNA induced inflammatory responses. NF-κB signaling is also induced upon HIV-1 infection which leads to the production of pro-inflammatory cytokines to control the viral spread. Further investigations revealed that SOCS3 inhibits the expression and activity of p65 by interacting with it and inducing its ubiquitin-dependent proteasomal degradation. SH2 domain was critical for SOCS3-p65 interaction and p65 degradation. We also found that expression of SOCS3 promotes HIV-1 replication. Thus, HIV-1 downregulates SOCS3 in early phase of infection to promote inflammatory responses for large production of activated cells which are suitable for viral spread and induces SOCS3 later on to limit inflammatory responses and ensure viral survival.


  • Open Access

    Serum deprivation/starvation leads to reactivation of HIV-1 in latently infected monocytes via activating ERK/JNK pathway

    by Rameez Raja, Sneh Lata, Shubhendu Trivedi, Akhil C. Banerjea

    Despite the high success rate, antiretroviral therapy does not cure the disease completely due to presence of latent viral reservoirs. Although several studies have addressed this issue earlier, the role of serum starvation/deprivation in HIV-1 latency has not been studied. So, we investigated the role of serum starvation in regulating HIV-1 latency. The impact of serum starvation on HIV-1 latency was assessed in latently infected monocytes U1 and T-cells J1.1. Serum starvation breaks HIV-1 latency in U1 cells. Under similar conditions, J1.1 cells failed to show reactivation of virus. We investigated the involvement of cell death pathway and autophagy during the serum starvation in viral reactivation. Inhibition of these pathways did not affect viral reactivation. Furthermore, other crucial factors like NF-κB, SP1 and AKT did not play any role in regulating viral latency. Here, we report that serum deprivation up-regulates ERK/JNK pathway. This leads to phosphorylation of c-Jun which plays an important role in viral reactivation. Treatment of cells with U0126, an ERK kinase inhibitor, potently inhibited viral replication. In summary, we show that serum starvation leads to reactivation of HIV-1 in latently infected monocytes through the ERK/JNK pathway.


  • Open Access

    In silico Analyses of Subtype Specific HIV-1 Tat-TAR RNA Interaction Reveals the Structural Determinants for Viral Activity

    by Larance Ronsard, Tripti Rai, Devesh Rai, Vishnampettai G. Ramachandran, Akhil C. Banerjea

    HIV-1 Tat transactivates viral genes through strong interaction with TAR RNA. The stem-loop bulged region of TAR consisting of three nucleotides at the position 23 to 25 and the loop region consisting of six nucleotides at the position 30 to 35 are essential for viral transactivation. The arginine motif of Tat (five arginine residues on subtype TatC) is critically important for TAR interaction. Any mutations in this motif could lead to reduce transactivation ability and pathogenesis. Here, we identified structurally important residues (arginine and lysine residues) of Tat in this motif could bind to TAR via hydrogen bond interactions which is critical for transactivation. Natural mutant Ser46Phe in the core motif could likely led to conformational change resulting in more hydrogen bond interactions than the wild type Tat making it highly potent transactivator. Importantly, we report the possible probabilities of number of hydrogen bond interactions in the wild type Tat and the mutants with TAR complexes. This study revealed the differential transactivation of subtype B and C Tat could likely be due to the varying number of hydrogen bonds with TAR. Our data support that the N-terminal and the C-terminal domains of Tat is involved in the TAR interactions through hydrogen bonds which is important for transactivation. This study highlights the evolving pattern of structurally important determinants of Tat in the arginine motif for viral transactivation.


  • Open Access

    HIV-1 Tat potently stabilises Mdm2 and enhances viral replication

    by Rameez Raja, Larance Ronsard, Sneh Lata, Shubhendu Trivedi, Akhil C. Banerjea

    Murine double minute 2 (Mdm2) is known to enhance the transactivation potential of human immunodeficiency virus (HIV-1) Tat protein by causing its ubiquitination. However, the regulation of Mdm2 during HIV-1 infection and its implications for viral replication have not been well studied. Here, we show that the Mdm2 protein level increases during HIV-1 infection and this effect is mediated by HIV-1 Tat protein. Tat appears to stabilise Mdm2 at the post-translational level by inducing its phosphorylation at serine-166 position through AKT. Although p53 is one of the key players for Mdm2 induction, Tat-mediated stabilisation of Mdm2 appears to be independent of p53. Moreover, the non-phosphorylatable mutant of Mdm2 (S166A) fails to interact with Tat and shows decreased half-life in the presence of Tat compared with wild-type Mdm2. Furthermore, the non-phosphorylatable mutant of Mdm2 (S166A) is unable to support HIV-1 replication. Thus, HIV-1 Tat appears to stabilise Mdm2, which in turn enhances Tat-mediated viral replication. This study highlights the importance of post-translational modifications of host cellular factors in HIV-1 replication and pathogenesis.


  • USP7 deubiquitinase controls HIV-1 production by stabilizing Tat protein

    by Amjad Ali, Rameez Raja, Sabihur Rahman Farooqui, Shaista Ahmad, Akhil C. Banerjea

    Deubiquitinases (DUBs) are key regulators of complex cellular processes. HIV-1 Tat is synthesized early after infection and is mainly responsible for enhancing viral production. Here, we report that one of the DUBs, USP7, stabilized the HIV-1 Tat protein through its deubiquitination. Treatment with either a general DUB inhibitor (PR-619) or USP7-specific inhibitor (P5091) resulted in Tat protein degradation. The USP7-specific inhibitor reduced virus production in a latently infected T-lymphocytic cell line J1.1, which produces large amounts of HIV-1 upon stimulation. A potent increase in Tat-mediated HIV-1 production was observed with USP7 in a dose-dependent manner. As expected, deletion of the USP7 gene using the CRISPR-Cas9 method reduced the Tat protein and supported less virus production. Interestingly, the levels of endogenous USP7 increased after HIV-1 infection in human T-cells (MOLT-3) and in mammalian cells transfected with HIV-1 proviral DNA. Thus, HIV-1 Tat is stabilized by the host cell deubiquitinase USP7, leading to enhanced viral production, and HIV-1 in turn up-regulates the USP7 protein level.


  • Open Access

    Hyperactivation of mammalian target of rapamycin complex 1 by HIV‐1 is necessary for virion production and latent viral reactivation

    by Binod Kumar, Sakshi Arora, Shaista Ahmed, Akhil C. Banerjea

    Generation of new HIV‐1 virions requires the constant supply of proteins, nucleotides, and energy; however, it is not known which cellular pathways are perturbed and what molecular mechanisms are employed. We hypothesized that HIV‐1 may regulate pathways that control synthesis of biomolecules in the cell. In this study, we provide evidence that HIV‐1 hyperactivates mammalian target of rapamycin complex 1 (mTORC1), the central regulator of biosynthesis. Mechanistically, we identify the viral regulatory gene tat (transactivator) as being responsible for increasingm TORC1 activity in aPI3K‐dependentmanner. Furthermore, we show that hyperactivation of mTORC1 leads to activation of the enzyme, carbamoyl‐phosphate synthetase 2, aspartate transcarbamylase, dihydroorotase, and repression of initiation factor 4E‐binding protein 1 activity. These are regulators of nucleotide biogenesis and protein translation, respectively. Moreover, we are able to replicate these results inHIV‐1 latent cell line models. Finally, we show that inhibition of mTORC1or PI3K inhibits viral replication and viral reactivation as a result of a decrease in biosynthesis. Overall, our study identifies a new avenue in HIV‐1 biology that can lead to development of novel therapeutic targets.—Kumar, B., Arora, S., Ahmed, S., Banerjea, A. C. Hyperactivation of mammalian target of rapamycin complex 1 by HIV‐1 is necessary for virion production and latent viral reactivation. FASEB J. 31, 180–191 (2017) www.fasebj.org